News

Incyte announces that its study of povorcitinib revealed sustained and durable efficacy after 1 year.

The development of xerosis in mature skin was analyzed in a poster presentation from SBS 2023.

Ronda Farah, MD, gave an in-depth overview of aesthetic procedures to understand for LGBTQ+ patients at SBS 2023.

Laura Ferris, MD, PhD, discusses the future landscape of artificial intelligence and skin cancer detection at SBS 2023.

Ablon’s sessions at SBS 2023 covered filler complications and the future of exosomes.

Catch up on coverage from the first day of South Beach Symposium.

David Goldberg, MD, JD, explores the increasing rates of melanoma in the US and how to manage melanoma subtypes at SBS 2023.

A poster presentation from SBS 2023 analyzed the relationship between dermatology and social media.

Discover fun activities to explore while attending South Beach Symposium 2023.

Farberg shares key pearls from his session on when to use hedgehog inhibitors at South Beach Symposium 2023.

The 2023 South Beach Symposium meeting begins today in Miami Beach, Florida.

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Benjamin Bashline, DO, to discuss men's health.

This article reviews equity-indexed life insurance policies and structured notes, instruments that offer investment protection and growth potential.

As a dozen Humira Biosimilars are set to enter the market this year, it seems to be unlikely that they will drive down drug costs in the future.

This week's edition of the Mainstream Patient features stories about recommended razors for keratosis pilaris, dermatologist-recommended retinol serums, how to patch test skin care products, and more.

Merkel cell carcinoma is a rare but highly aggressive type of nonmelanoma skin cancer and Merkel cell polyomavirus is thought to play a major role in its etiology.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses fragrances in skin care products.

Newly released safety and efficacy data on Novartis’ secukinumab for hidradenitis suppurativa is published in The Lancet.

ICYMI, this week we had stories about adalimumab biosimilars, an expanded Banana Boat Hair & Scalp Sunscreen recall, what's trending in skin care for January 2023, and more.

This month's Legal Eagle column explores what information is required during an informed consent discussion.

Atopic dermatitis is not a "one-size-fits-all" condition.

It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.

This week's edition of the Mainstream Patient features stories about sensitive skin around the eyes, health risks of sharing razors, keratin shampoos for stronger hair, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses botox and other cosmetic treatments with Matthew Elias, DO, FAAD.

Explore a collection of the best skin tips for patients with skin of color.

Granulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.

Learn more about what in-depth topics were covered in the January 2023 issue of Dermatology Times.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of January.

Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.

Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss the benefits of adalimumab-atto and the future of additional biosimilars in 2023.